mitoxantrone has been researched along with Infantile Respiratory Distress Syndrome in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salvucci, M | 1 |
| Zanchini, R | 1 |
| Molinari, A | 1 |
| Zuffa, E | 1 |
| Poletti, V | 1 |
| Poletti, G | 1 |
| Zaccaria, A | 1 |
1 other study available for mitoxantrone and Infantile Respiratory Distress Syndrome
| Article | Year |
|---|---|
Lung toxicity following fludarabine, cytosine arabinoside and mitoxantrone (flan) treatment for acute leukemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Hemorrhage; Humans; I | 2000 |